Boston Scientific

1. Boston Scientific Recalls 2 Types Of Defibrillator

Monday, Mar 15, 2010

Boston Scientific Corp. has announced it is recalling two defibrillator types because it failed to inform the U.S. Food and Drug Administration of manufacturing process changes.

2. Calif. Appeals Court Backs MDA Preemption Clause

Wednesday, Mar 10, 2010

A California appeals court has affirmed a finding that state law claims against Guidant Corp. and others responsible for the allegedly defective Ancure Endograft System are preempted by the Medical Device Amendments of 1976, furthering the Riegel decision's reach.

3. Boston Scientific Cross-Appeals Stent Patent Ruling

Wednesday, Mar 03, 2010

Weeks after Johnson & Johnson Inc. appealed a federal court's ruling that four of its patents for drug-eluting stents are invalid, Boston Scientific Corp. has notified the court that it will also appeal parts of that case.

4. Arnold & Porter Star Opts For Davis Polk, Not Retirement

Tuesday, Mar 02, 2010

Arnold & Porter LLP's loss is Davis Polk & Wardwell LLP's gain, with the firm's former chairman, 69-year-old Michael N. Sohn, relinquishing his position as partner to join Davis Polk as counsel due to Arnold & Porter's mandatory retirement policy.

5. DOJ Charges Guidant In Faulty Defibrillator Case

Thursday, Feb 25, 2010

The U.S. Department of Justice has formally filed criminal charges against Boston Scientific Corp. unit Guidant LLC, claiming the company concealed significant safety problems with some of its cardiac defibrillators in violation of the Federal Food, Drug and Cosmetic Act.

6. J&J Can't Revive Claims Against Abbott, Boston Sci

Thursday, Feb 18, 2010

A federal judge has ruled that Johnson & Johnson cannot amend its complaint to resurrect its breach of contract and anti-competitive conduct claims against Abbott Laboratories and Boston Scientific Corp. in a $5.5 billion suit over its failed bid to acquire Guidant Corp.

7. J&J Appeals Invalidity Ruling For Stent Patents

Thursday, Feb 18, 2010

Johnson & Johnson Inc. has appealed a federal court's ruling in favor of plaintiff Boston Scientific Corp. that four of J&J's patents for drug-eluting stents are invalid.

8. Howrey To Remain As BSC Counsel In Stent IP Suit

Tuesday, Feb 09, 2010

A district judge has reversed a magistrate judge's order disqualifying Howrey LLP from defending Boston Scientific Corp. in a patent infringement suit brought by Wyeth over drug-eluting stents, holding that the firm's representation of Wyeth in an unrelated case does not create a significant conflict of interest.

9. Off-Label Marketing Ripe For Enforcement In 2010

Friday, Feb 05, 2010

Last year saw blockbuster settlements in off-label marketing cases, including the two largest such payments ever. And with the Obama administration's commitment to strong enforcement of consumer protection laws showing no signs of letting up, attorneys are predicting 2010 will bring even more legal activity and large penalties in the area of off-label marketing.

10. AtriCure Settles Medicare Fraud Claims For $3.8M

Wednesday, Feb 03, 2010

Medical device maker AtriCure Inc. has reached a $3.76 million settlement with the U.S. Department of Justice, putting to rest claims that the company improperly marketed devices used to treat abnormal heart rhythms and enticed physicians and hospitals to inflate Medicare costs related to their use.

11. ERISA Suits Show No Sign Of Abating

Tuesday, Feb 02, 2010

Employee Retirement Income Security Act settlements raked in over $400 million in 2009, and while many of these cases arose from the financial crisis, lawyers say there are no indications that litigation will recede even after big business regains strength.

12. Boston Scientific To Pay J&J $1.7B In Stent Settlement

Monday, Feb 01, 2010

Boston Scientific Corp. has agreed to pay Johnson & Johnson Inc. $1.725 billion to resolve a handful of stent patent disputes between the companies, including two that had been set to go to trial Monday.

13. Cos. Pay Big To Settle Patent Fights With Rivals

Friday, Jan 29, 2010

Facing tighter budgets and a teetering economy, many technology and medical companies opted to shell out some gigantic settlement payments in 2009 to forgo waging potentially more expensive and time-draining patent litigation battles against industry rivals.

14. J&J Stent Patents Found Invalid In Boston Sci Suit

Thursday, Jan 21, 2010

Boston Scientific Corp. has prevailed in a consolidated suit against Johnson & Johnson Inc., now that a federal judge has found invalid four J&J patents for a drug-eluting stent.

15. Boston Scientific Stent Patent Suit Moved To NJ

Tuesday, Jan 19, 2010

A federal judge on Tuesday denied motions by Wyeth and Cordis Corp. to dismiss a declaratory action brought against them by Boston Scientific Corp. over a patent for drug-coated stents.

16. Cordis Sues Boston Scientific Over Stent Patents

Tuesday, Jan 19, 2010

Johnson & Johnson unit Cordis Corp. has launched a new patent infringement suit against rival Boston Scientific Corp., claiming BSC's Promus drug-eluting stents infringe three patents and unfairly compete with Cordis' Cypher stent sales.

17. SLU Hospital Escapes Guidant Defibrillator MDL

Tuesday, Jan 19, 2010

Saint Louis University Hospital has won its way out of the massive multidistrict litigation involving Guidant Corp.'s recalled implantable heart defibrillators because a group of plaintiffs failed to file a health care affidavit within the required period of time.

18. Abbott, Others Marketed Stents Off-Label: Suit

Friday, Jan 15, 2010

Boston Scientific Corp., Abbott Laboratories and Cordis Corp. engaged in an off-label marketing scheme to promote digestive tract stents for unapproved use in other parts of the body, according to a recently unsealed whistleblower suit by a former medical device executive.

19. Kirkland & Ellis Patent Pro Joins Quinn Emanuel

Thursday, Jan 14, 2010

Patent litigator Peter Armenio has joined the New York office of international law firm Quinn Emanuel Urquhart Oliver & Hedges LLP from rival Kirkland & Ellis LLP.

20. High Court Rebuffs Boston Scientific Section 271(f) Suit

Monday, Jan 11, 2010

The U.S. Supreme Court has declined to hear a Boston Scientific Corp. subsidiary's appeal of its infringement suit against St. Jude Medical Inc. over patents covering implantable defibrillators, leaving in place a federal appeals court ruling that 35 U.S.C. Section 271(f) does not apply to method patents.